Structural Biology in Drug Discovery 2020
DOI: 10.1002/9781118681121.ch18
|View full text |Cite
|
Sign up to set email alerts
|

Epigenetic Proteins as Emerging Drug Targets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 207 publications
0
1
0
Order By: Relevance
“…[11][12][13][14] Protein lysine methyltransferases (PKMTs) are the posttranslationally-modifying enzymes that catalyze lysine methylation with S-adenosyl-L-methionine (SAM) as a cofactor. 11,[15][16] The methods using experimental binding and kinetic isotope effects (BIE and KIEs) as geometrical constraints coupled with computational modeling allow to uncover atomistic details of the TS structures of PKMT-catalyzed methylation reactions. [17][18] Similar to other homologous enzymes, closely related PKMTs can adopt distinct TS as revealed by a collection of characteristic KIEs.…”
mentioning
confidence: 99%
“…[11][12][13][14] Protein lysine methyltransferases (PKMTs) are the posttranslationally-modifying enzymes that catalyze lysine methylation with S-adenosyl-L-methionine (SAM) as a cofactor. 11,[15][16] The methods using experimental binding and kinetic isotope effects (BIE and KIEs) as geometrical constraints coupled with computational modeling allow to uncover atomistic details of the TS structures of PKMT-catalyzed methylation reactions. [17][18] Similar to other homologous enzymes, closely related PKMTs can adopt distinct TS as revealed by a collection of characteristic KIEs.…”
mentioning
confidence: 99%